Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1471958 | Deacetylnorgestimate (E)- and (Z)-17-deacetyl norgestimate mixture | 25 mg |
| USP-1472000 | Norgestrel | 125 mg |
| USP-1473002 | Noroxymorphone Hydrochloride (HCl) CII (controlled substance in USA) | 50 mg |
| USP-1473206 | Norphenylephrine Hydrochloride | 25 mg |
| USP-1474005 | Nortriptyline Hydrochloride (HCl) | 200 mg |
| USP-1474504 | Noscapine | 100 mg |
| USP-1475008 | Novobiocin | 200 mg |
| USP-1477003 | Nystatin - Released from Quarantine with Customer Support Guidance (15-Dec-2016) (COLD SHIPMENT REQUIRED) | 200 mg |
| USP-1477411 | Octocrylene | 500 mg |
| USP-1477502 | Octoxynol 9 | 200 mg |
| USP-1477604 | Octreotide Acetate (COLD SHIPMENT REQUIRED) | 4,37 mg |
| USP-1477615 | Octreotide Non-Cyclic System Suitability Marker (COLD SHIPMENT REQUIRED) | 20 mg |
| USP-1477808 | Octyldodecanol | 200 mg |
| USP-1477900 | Octinoxate (Octyl Methoxycinnamate) | 500 mg |
| USP-1477943 | Octisalate (Octyl Salicylate) | 400 mg |
| USP-1478108 | Ofloxacin | 200 mg |
| USP-1478119 | Ofloxacin Related Compound A - 9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 25 mg |
| USP-1478130 | Oleic Acid | 1 g |
| USP-1478152 | Oleoyl Polyoxylglycerides | 100 mg |
| USP-1478200 | Oley Oleate | 0,5 mL |
| USP-1478254 | Olive Oil (AS) | 1 g |
| USP-1478301 | Olanzapine | 200 mg |
| USP-1478312 | Olanzapine Related Compound A - 5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile | 15 mg |
| USP-1478323 | Olanzapine Related Compound B - 2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one | 15 mg |
| USP-1478334 | Olanzapine Related Compound C - 2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4'-N-oxide (COLD SHIPMENT REQUIRED) | 5 mg |
| USP-1478367 | Olmesartan Medoxomil | 100 mg |
| USP-1478378 | Olmesartan Medoxomil Related Compound A - 1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one | 20 mg |
| USP-1478403 | Olopatadine Hydrochloride (HCl) | 150 mg |
| USP-1478425 | Olopatadine Related Compound B - (Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide | 35 mg |
| USP-1478436 | Olopatadine Related Compound C - (11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid | 35 mg |
| USP-1478491 | Omeprazole Related Compound F and G Mixture | 25 mg |
| USP-1478505 | Omeprazole | 200 mg |
| USP-1478516 | Omeprazole Related Compound A - Omeprazole Sulfone or 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole | 15 mg |
| USP-1478527 | Omeprazole Related Compound E | 15 mg |
| USP-1478549 | Omeprazole Magnesium | 10 mg |
| USP-1478561 | (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide) | 15 mg |
| USP-1478571 | Ondansetron | 300 mg |
| USP-1478582 | Ondansetron Hydrochloride (HCl) | 300 mg |
| USP-1478593 | Ondansetron Related Compound A - 3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride | 50 mg |
| USP-1478618 | Ondansetron Related Compound C - 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one | 30 mg |
| USP-1478629 | Ondansetron Related Compound D - 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one | 30 mg |
| USP-1478630 | Ondansetron Resolution Mixture | 50 mg |
| USP-1478673 | Orbifloxacin | 350 mg |
| USP-1478800 | Orlistat | 200 mg |
| USP-1478811 | Orlistat Related Compound A - (3S,4S)3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone | 25 mg |
| USP-1478822 | Orlistat Related Compound B - diisopropyl bicarbamate | 10 mg |
| USP-1478833 | Orlistat Related Compound C - Triphenylphosphine oxide | 25 mg |
| USP-1478844 | Orlistat Related Compound D - N-formyl-L-leucine (3S,4R,6S)-tetrahydro-3-hexyl-2-oxo-6-undecyl-2H-pyran-4-yl ester | 10 mg |
| USP-1478855 | Orlistat Related Compound E - N-formyl-S-isoleucin-(S)-1-[[(2S, 3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester | 10 mg |
| USP-1479009 | Orphenadrine Citrate | 200 mg |
| USP-1479010 | Orphenadrine Related Compound A - (RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate (AS) | 50 mg |
| USP-1479020 | Orphenadrine Related Compound B - N-ethyl-N,N-dimethyl[2-[2-methylbenzhydryloxy)ethyl]ammonium chloride | 20 mg |
| USP-1479031 | Orphenadrine Related Compound C - N-methyl-[2-(2-methylbenhydryloxy)ethyl]amine hydrochloride | 20 mg |
| USP-1479304 | Oseltamivir Phosphate | 200 mg |
| USP-1479315 | Oseltamivir Related Compound A - (3S,4R,5S)-ethyl 4-acetamido-5-amino-2-azido-3-(penta-3-yloxy)cyclohexanecarboxylate | 10 mg |
| USP-1481000 | Oxacillin Sodium | 200 mg |
| USP-1481204 | Oxaliplatin | 125 mg |
| USP-1481215 | Oxaliplatin Related Compound A - Oxalic acid dihydrate | 100 mg |
| USP-1481226 | Oxaliplatin Related Compound B - [SP-4-2-(1R-trans-)]-(1,2-cyclohexanediamine-N,N')dinitratoplatinum (II) | 15 mg |
| USP-1481237 | Oxaliplatin Related Compound C - [1R-trans-(1,2-cyclohexanediamine-N,N')]-trans-dihydroxido-[oxalato(2-)-O,O']platinum (IV) | 20 mg |
| USP-1481248 | Oxaliplatin Related Compound D - cis[(1S,2S)-1,2-cyclohexanediamine-N,N'][oxalato(2-)-O,O']platinum | 10 mg |
| USP-1481260 | Oxaliplatin Related Compound F - [SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N-N')diiodidoplatinum(II) | 25 mg |
| USP-1481306 | Oxaliplatin System Suitability [SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N')dichloridoplatinum (II) | 25 mg |
| USP-1482003 | Oxandrolone CIII (controlled substance in USA) | 50 mg |
| USP-1482014 | Oxandrolone Related Compound A - 17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one CIII (controlled substance in USA) | 20 mg |
| USP-1482025 | Oxandrolone Related Compound B - 17 beta-hydroxy-17-alpha-methyl-4-oxa-5 alpha-androsta-3-one CIII (controlled substance in USA) | 20 mg |
| USP-1482036 | Oxandrolone Related Compound C - 17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one CIII (controlled substance in USA) | 20 mg |
| USP-1482207 | Oxaprozin | 200 mg |
| USP-1483152 | Oxcarbazepine | 100 mg |
| USP-1483163 | Oxcarbazepine Related Compound A - N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide | 10 mg |
| USP-1483174 | Oxcarbazepine Related Compound B - N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide | 10 mg |
| USP-1483185 | Oxcarbazepine Related Compound C - Acridin-9(10H)-one | 10 mg |
| USP-1483196 | Oxcarbazepine Related Compound D (10-(10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamido)-5H- | 10 mg |
| USP-1483200 | Oxcarbazepine Related Compound E - 10(11H)-Oxo-5H-dibenz[b,f]azepine | 10 mg |
| USP-1483301 | Oxfendazole | 200 mg |
| USP-1483505 | Oxprenolol Hydrochloride (HCl) | 200 mg |
| USP-1484009 | Oxtriphylline | 500 mg |
| USP-1485001 | Oxybenzone | 150 mg |
| USP-1485103 | Oxybutynin Chloride | 200 mg |
| USP-1485114 | Oxybutynin Related Compound A - Phenylcyclohexylglycolic Acid | 100 mg |
| USP-1485125 | Oxybutynin Related Compound B - Cyclohexyl mandelic acid methyl ester | 20 mg |
| USP-1485136 | Oxybutynin Related Compound C - 4-(Ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride | 20 mg |
| USP-1485216 | Oxycodone Related Compound A - 14-hydroxycodeinone CII (controlled substance in USA) (COLD SHIPMENT REQUIRED) | 10 mg |
| USP-1485227 | Oxycodone Related Compound B - Oxycodone N-oxide CII (controlled substance in USA) | 15 mg |
| USP-1485238 | Oxycodone Related Compound C - Codeinone CII (controlled substance in USA) | 15 mg |
| USP-1486004 | Oxymetazoline Hydrochloride (HCl) | 200 mg |
| USP-1487007 | Oxymetholone CIII (controlled substance in USA) | 200 mg |
| USP-1490103 | Oxyquinoline Sulfate | 200 mg |
| USP-1491004 | Oxytetracycline | 200 mg |
| USP-1491015 | Oxytetracycline Hydrochloride (HCl) | 200 mg |
| USP-1491296 | Oxytocin Identification (COLD SHIPMENT REQUIRED) | 15 mg |
| USP-1491300 | Oxytocin (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | unit |
| USP-1491332 | Paclitaxel | 200 mg |
| USP-1491343 | Paclitaxel Related Compound A - Cephalomannine | 20 mg |
| USP-1491354 | Paclitaxel Related Compound B - 10-Deacetyl-7-epipaclitaxel | 20 mg |
| USP-1491365 | Paclitaxel Impurity Mixture | 10 mg |
| USP-1491503 | Padimate O | 300 mg |
| USP-1491809 | Paliperidone (additional transportation cost) | 200 mg |
| USP-1491818 | Paliperidone Related Compound A - 3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-alpha]pyrimidin-4-one | 20 mg |
| USP-1491820 | Paliperidone Related Compound B - 6-fluoro-3-(piperidin-4-yl)benzoisoxazole Hydrochloride (HCl) | 20 mg |